JXHS1900041 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2019-04-03 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | In Review | 2019-04-02 | view |
JXHS1900040 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2019-04-03 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | In Review | 2019-04-02 | view |
JXHS1900044 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2019-04-03 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | In Review | 2019-04-02 | view |
JXHS1900043 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2019-04-03 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | In Review | 2019-04-02 | view |
JXHS1900042 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2019-04-03 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | In Review | 2019-04-02 | view |
JXHL1600126 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2016-11-30 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2017-08-22 | view |
JXHL1600125 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2016-11-30 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2017-08-22 | view |
JXHL1600124 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2016-11-30 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2017-08-22 | view |
JXHL1600123 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2016-11-30 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2017-08-22 | view |
JXHL1600127 | 盐酸普拉克索缓释片 | pramipexole dihydrochloride | Tablet, extended release | Chemical Drugs(5.2) | Import Drug Application | 2016-11-30 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2017-08-22 | view |
JXHL1400055 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Import Drug Application | 2014-12-29 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2016-09-27 | view |
JXHL1400332 | 奥氮平口崩片 | olanzapine | Tablet | Chemical Drugs | Import Drug Application | 2014-10-24 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2016-10-21 | view |
JXHL1400333 | 奥氮平口崩片 | olanzapine | Tablet | Chemical Drugs | Import Drug Application | 2014-10-20 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2016-10-21 | view |
JXHL1400056 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Import Drug Application | 2014-02-20 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2016-09-13 | view |
JXHL1400057 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Import Drug Application | 2014-02-20 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2016-09-13 | view |
JXHS1300024 | 奥沙利铂 | oxaliplatin | Active ingredient | Chemical Drugs | Import Drug Application | 2013-04-10 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | In Review | 2013-04-08 | view |
JXHS1300019 | 盐酸替罗非班 | Tirofiban Hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2013-03-07 | 北京金康驰医药投资有限公司 | Beijing King Health Investment Co Ltd | Certificate Issued | 2015-08-25 | view |